KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Beginning Cash Balance: 2009-2024

Historic Beginning Cash Balance for Bausch Health Companies (BHC) over the last 16 years, with Dec 2024 value amounting to $942.0 million.

  • Bausch Health Companies' Beginning Cash Balance rose 189.02% to $1.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $718.0 million, marking a year-over-year decrease of 4.14%. This contributed to the annual value of $942.0 million for FY2024, which is 63.54% up from last year.
  • As of FY2024, Bausch Health Companies' Beginning Cash Balance stood at $942.0 million, which was up 63.54% from $576.0 million recorded in FY2023.
  • Bausch Health Companies' Beginning Cash Balance's 5-year high stood at $2.1 billion during FY2022, with a 5-year trough of $279.0 million in FY2021.
  • Over the past 3 years, Bausch Health Companies' median Beginning Cash Balance value was $942.0 million (recorded in 2024), while the average stood at $1.2 billion.
  • In the last 5 years, Bausch Health Companies' Beginning Cash Balance slumped by 86.28% in 2021 and then spiked by 649.82% in 2022.
  • Bausch Health Companies' Beginning Cash Balance (Yearly) stood at $2.0 billion in 2020, then slumped by 86.28% to $279.0 million in 2021, then spiked by 649.82% to $2.1 billion in 2022, then crashed by 72.47% to $576.0 million in 2023, then skyrocketed by 63.54% to $942.0 million in 2024.